Panchgavya represents milk, urine, dung, ghee, and curd, derived from cow and serves irreplaceable medicinal importance in Ayurveda and traditional Indian clinical practices. In Ayurveda, Panchgavya treatment is termed as ‘Cowpathy’. In India, the cow is worshipped as a god called ‘Gaumata,’ indicating its nourishing nature like a mother. Ayurveda recommends Panchagavya to treat diseases of multiple systems, including severe conditions, with almost no side-effects. It can help build a healthy population, alternative sources of energy, complete nutritional requirements, eradicate poverty, pollution-free environment, organic farming, etc. Panchgavya can also give back to mother nature by promoting soil fertility, earthworm production, protecting crops from bacterial and fungal infections, etc. Scientific efforts shall be taken to build evidence for the clinical application of Cowpathy. The present review aims to summarize the health and medicinal benefits of Panchgavya.
1 October 2017 in European Journal of Pharmaceutical Sciences
In an attempt to improve the solubility and permeability of Standardized Bacopa Extract (SBE), a complexation approach based on phospholipid was employed. A solvent evaporation method was used to prepare the SBE-phospholipid complex (Bacopa Naturosome, BN). The formulation and process variables were optimized using a central-composite design. The formation of BN was confirmed by photomicroscopy, Scanning Electron Microscopy (SEM), Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC), and Powder X-ray Diffraction (PXRD). The saturation solubility, the in-vitro dissolution, and the ex-vivo permeability studies were used for the functional evaluation of the prepared complex. BN exhibited a significantly higher aqueous solubility compared to the pure SBE (20-fold), or the physical mixture of SBE and the phospholipid (13-fold). Similarly, the in-vitro dissolution revealed a significantly higher efficiency of the prepared complex (BN) in releasing the SBE (>97%) in comparison to the pure SCE (~42%), or the physical mixture (~47%). The ex-vivo permeation studies showed that the prepared BN significantly improved the permeation of SBE (>90%), compared to the pure SBE (~21%), or the physical mixture (~24%). Drug-phospholipid complexation may thus be a promising strategy for solubility enhancement of bioactive phytoconstituents.
13 June 2016 in Pharmaceutical Development and Technology
In the present study, a lyophilized milk-based solid dispersion (SD) of ritonavir (RTV) was developed with the goal of improving its aqueous solubility. The SD was prepared by lyophilization, and characterized for its physicochemical and functional properties. Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), scanning electron microscopy (SEM), photomicroscopy and powder X-ray diffraction (PXRD) were used to confirm the formation and robustness of the SD formulation. The prepared SD formulations were functionally evaluated by saturation solubility, in vitro drug release and ex vivo permeation studies. The optimized SD formulation exhibited a significantly higher (30-fold) aqueous solubility (11.36 ± 0.06 μg/mL), compared to the pure RTV (0.37 ± 0.03 μg/mL). The in vitro dissolution studies revealed a significantly higher (∼10-fold) efficiency of the optimized SD formulation in releasing the RTV, compared to the pure RTV. The ex vivo permeation studies with the everted intestine method showed that prepared SD formulation significantly improved the permeation of RTV (75.6 ± 3.09, % w/w), compared to pure RTV (20.45 ± 1.68, % w/w). Thus, SD formulation utilizing lyophilized milk as a carrier appears to be a promising alternative strategy to improve the aqueous solubility of poorly water soluble drugs.
Background: Dillenia indica L. (Dilleniaceae) and Anogeissus leiocarpus (DC.) Guill. & Perr. (Combretaceae) are used in traditional Nigerian medicine to treat various forms of cancer. This study investigated the cytotoxic effects of these plant extracts using COV434 granulosa tumor and MCF-7 breast cancer cells.Methods: Samples of D. indica and A. leiocarpus were collected in Ibadan, Nigeria, air-dried, and extracted with methanol. Cell viability and cytotoxicity were determined using CellTiter-Glo® 2.0 assay at concentrations from 1 to 100 μg/mL. Caspase activity and apoptosis were determined using Caspase-Glo® 3/7, Caspase-Glo® 8, and ApoTox-Glo™ triplex assays, and qPCR. Autophagy was measured using a Cyto-ID Autophagy Detection Kit.Results: In COV434, aqueous partitions of A. leiocarpus root (ALR-Aq) and stem bark (ALS-Aq) had IC50sof 23.5 and 26.7 μg/mL, respectively. In MCF-7 cells, the ALR MeOH extract had IC50of 12.75 μg/mL, while the DIS-Aq had IC50of 65.28 μg/mL. None of the extracts inhibited the growth of human osteoblasts or rat myoblasts at similar concentrations. Treatment with ALR-Aq and DIS-Aq induced mitochondrial apoptosis in MCF-7 and COV434. Both ALR-Aq and DIS-Aq induced autophagy in COV434 cells, while ALR-Aq induced autophagy in MCF-7 cells. Ellagic acid (IC50of 3.27μg/mL in COV434 cells) was isolated from ALR-Aq using bioassay-guided fractionation.Conclusion: DIS-Aq and ALR-Aq induced apoptosis in MCF-7 and COV434 cancer cells. Ellagic acid was isolated as the active constituent. Taken together, these data suggest that both plant extracts have strong anti-proliferative effects, and further investigation for their anticancer effects is warranted.
Osteoporosis is a major public health concern and is characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to bone fragility and an increased susceptibility to fractures. Osteoporosis and osteopenia affect over 45 million Americans annually with an estimated cost of > $20 billion USD. Over 50% of women and ~13% of men over the age of 50 will suffer an osteoporosis‐related fracture in their lifetime resulting in loss of independence, health and productivity, thus the research and discovery of compounds that can enhance bone formation would be clinically significant. Blackcurrants ( Ribes nigrum ) are native to Central and Eastern Europe and Northern Asia and are used in traditional medicine for the treatment of cardiovascular disease, bone and muscle disorders, diabetes, viral infections and inflammation. The berries contain four major anthocyanins: delphinidin‐3‐O‐glucoside, delphinidin‐3‐O‐rutinoside, cyanidin‐3‐O‐glucoside, cyanidin‐3‐O‐rutinoside. We have previously shown that blackcurrant extracts (BCE) increase myoblastogenesis, and in this work, we investigate its effects in cultured hFOB human osteoblasts and osterix/Sp7:mCherry transgenic medaka. hFOB human osteoblasts were obtained from ATCC and cultured in 1:1 mixture of Ham's F12 Medium Dulbecco's Modified Eagle's medium, with 2.5 mM L‐glutamine (without phenol red). Double transgenic medaka (dT; osterix/Sp7 :mCherry were maintained at UIC under protocol #17‐166. Larvae at 9–12 dpf were staged and then treated for 5 days with the extracts and compounds (1–10 mg/ml). Osteoblast formation and distribution were analyzed by fluorescence microscopy, bone mineralization was visualized by calcein. The results of this investigation demonstrate that BCE and delphinidin‐3‐glucose increased osteoblast proliferation and reduced apoptosis in cultured human osteoblasts (hFOB) by reducing Bax and p53 expression and altering HDAC1, HDAC3, SIRT 3 and PGC1amRNA expression. In osterix/Sp7 :mCherry medaka, BCE treatment (10 mg/ml) increased osteoblast proliferation by increasing osterix/Sp7 expression. These data suggest that BCE and D3G increase osteoblastogenesis through epigenetic regulation of HDACs and mitochondrial biogenesis. Support or Funding Information NCCIH at the National Institutes of Health This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .